Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2003; 41:136-141
© 2003 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Poggianti, E.
Right arrow Articles by Picano, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Poggianti, E.
Right arrow Articles by Picano, E.

Aortic valve sclerosis is associatedwith systemic endothelial dysfunction

Elisa Poggianti, RN*, Lucia Venneri, MD*, Vlad Chubuchny, MD*, Zoltan Jambrik, MD*, Liz Andrea Baroncini, MD* and Eugenio Picano, MD, PhD*,*

* Echocardiography Laboratory, Institute of Clinical Physiology, CNR, Pisa, Italy



View larger version (16K):

[in a new window]
 
Figure 1 Endothelium-dependent flow-mediated dilation (FMD) of the brachial artery during reactive hyperemia (endothelium-dependent vasomotion) is significantly higher in subjects with no evidence of aortic valve sclerosis (AVS) than in patients with AVS. Data are expressed as the median value (25% and 75% and outliers, in a "box-and-whiskers" plot). *p < 0.002.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement